Author： Camilleri M.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.17, Iss.4, 2000-04, pp. : 331-338
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alosetron in Irritable Bowel Syndrome: Strategies for its Use in a Common Gastrointestinal Disorder
By Lembo A.
Drugs, Vol. 63, Iss. 18, 2003-01 ,pp. :
Access to resources
Recommend
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. :
Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria
By Badia X.
PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. :
Quality of Life in Irritable Bowel Syndrome
PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. :